← Back to Search

Behavioral Intervention

Contingency Management Therapies for Alcoholism

N/A

Recruiting

Led By Hagar Hallihan

Research Sponsored by University of Illinois at Chicago

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 6months

Awards & highlights

Study Summary

This trial tests a new therapeutic approach for young adults with Alcohol Use Disorder to improve treatment efficacy and better understand the brain effects.

Who is the study for?

This trial is for English-speaking young adults aged 18-24 who drink alcohol at least once a week and meet criteria for mild to severe Alcohol Use Disorder (AUD). They must have completed informed consent and a baseline screening visit. Specific details on exclusion criteria are not provided.Check my eligibility

What is being tested?

The study tests an integrated intervention called CM-PST against CM alone, aiming to improve treatment efficacy in AUD. It involves two phases: K99 checks the new method's feasibility and acceptability; R00 compares both methods' effectiveness over six months with primary focus at three months, including brain scans to explore neural mechanisms.See study design

What are the potential side effects?

Since this trial focuses on behavioral interventions rather than medications, traditional side effects like those seen with drugs may not apply. However, participants might experience discomfort or emotional distress during therapy sessions or fMRI scans.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 6months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 6months

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 6months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Alcohol abstinence.

Secondary outcome measures

Change in AUD screening status.

Change in AUD severity at 3 months.

Change in AUD severity at 6 months.

+13 more

Other outcome measures

Intervention Acceptability (K99 phase only).

Intervention Acceptability from interviews (K99 phase only).

Intervention Fidelity (K99 phase only).

+1 more

Trial Design

2Treatment groups

Experimental Treatment

Group I: Treatment groupExperimental Treatment1 Intervention

For the R00 phase: CM-PST treatment group will receive CM-PST intervention, which will consist of 8 sessions total, delivered remotely via Zoom videoconferences in individual sessions over 12 weeks. The first 4 sessions will be delivered weekly, and the remaining 4 sessions every other week. CM-PST will teach participants problem-solving skills using a structured 5-step method. In addition, participants will receive incentives for alcohol abstinence and submission of urine samples twice/wk. K99 phase participants will also receive CM-PST intervention.

Group II: Control groupExperimental Treatment1 Intervention

For the R00 phase: Participants in CM-only control will receive incentives for alcohol abstinence and submission of urine samples twice/wk. Participant incentives will start at a $10 gift card, with a $5 increase each subsequent measurement point on which alcohol is not detected or reported, to a maximum of $25, but no gift card on days when alcohol use is detected or reported, and the gift card reinforcer value will be re-set to $10.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

CM-PST

2013

N/A

~110

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

National Institute on Alcohol Abuse and Alcoholism (NIAAA)NIH

802 Previous Clinical Trials

1,365,341 Total Patients Enrolled

424 Trials studying Alcoholism

985,764 Patients Enrolled for Alcoholism

University of Illinois at ChicagoLead Sponsor

609 Previous Clinical Trials

1,559,205 Total Patients Enrolled

2 Trials studying Alcoholism

1,312 Patients Enrolled for Alcoholism

Hagar HallihanPrincipal InvestigatorUniversity of Illinois at Chicago

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this trial currently looking to enroll new participants?

"According to clinicaltrials.gov, this scientific trial is currently recruiting volunteers with an original start date of July 30th 2023 and a recent update from November 27th 2023."

Answered by AI

What is the cap for participant involvement in this research endeavor?

"Yes, the clinicaltrials.gov database indicates that this trial is currently recruiting patients. This research was initially posted on July 30th 2023 and has since been updated on November 27th of the same year. The study seeks to enrol 104 individuals from a single medical facility."

Answered by AI

Is this clinical trial accommodating those who have reached a certain age?

"This trial is available to individuals aged 18-24, with 19 trials specifically for those under the age of majority and 212 studies targeting persons over 65."

Answered by AI

Are there any criteria that would enable me to participate in this clinical investigation?

"This research project seeks a cohort of 104 male and female young adults aged 18 to 24 with an established history of alcoholism. Candidates must be English-speaking, have alcohol use greater or equal to 1 day in the past week, meet criteria for mild, moderate or severe AUD on the AUDIT and AUDADIS surveys., complete written informed consent and pass baseline screening study visit before participation can commence."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

StuDy AimED at Increasing AlCohol AbsTinEnce

Hagar Hallihan 2023. "StuDy AimED at Increasing AlCohol AbsTinEnce". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05778734.